June 2024. Volume 20. Number 2

Late mortality in patients of childhood cancers. Could we modify its incidence?

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Dixon SB, Liu Q, Chow EJ, Oeffinger KC, Nathan PC, Howell RM, et al. Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet 2023;401:1447-57.

Reviewers: Martínez Rubio M.V1, Perdikidis Olivieri L2.
1Pediatra. CS Los Fresnos. Torrejón de Ardoz. Madrid. España.
2Pediatra. EAP Juncal. Torrejón de Ardoz. Madrid. España.
Correspondence: M.ª Victoria Martínez Rubio. Email: victmrubio@gmail.com
Reception date: 05/04/2024
Acceptance date: 17/04/2024
Publication date: 24/04/2024

Abstract

Authors´ conclusions: childhood cancer survivors have an excess risk of late mortality even 40 years after diagnosis, due to the leading causes of death in the general population. A Better lifestyle and the absence of cardiovascular risk factors are associated with reductions in this risk and should be the focus of attention in the future.

Reviewers´ commentary: is a large, well-designed retrospective study of childhood cancer survivors, with a large patient sample and long follow-up, 40 years or more. An excess of long-term mortality is confirmed, and protective factors related to lifestyle and the absence of diabetes and high blood pressure are detected.

How to cite this article

Martínez Rubio V, Perdikidis Olivieri l. Mortalidad tardía en pacientes con cáncer infantil: ¿podríamos modificar su incidencia? Evid Pediatr. 2024;20:19.

AVC | Critically appraised articles

Dixon SB, Liu Q, Chow EJ, Oeffinger KC, Nathan PC, Howell RM, et al. Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet 2023;401:1447-57.

Reviewers: Martínez Rubio M.V1, Perdikidis Olivieri L2.
1Pediatra. CS Los Fresnos. Torrejón de Ardoz. Madrid. España.
2Pediatra. EAP Juncal. Torrejón de Ardoz. Madrid. España.
Correspondence: M.ª Victoria Martínez Rubio. Email: victmrubio@gmail.com
Reception date: 05/04/2024
Acceptance date: 17/04/2024
Publication date: 24/04/2024

How to cite this article

Martínez Rubio V, Perdikidis Olivieri l. Mortalidad tardía en pacientes con cáncer infantil: ¿podríamos modificar su incidencia? Evid Pediatr. 2024;20:19.

24/04/2024

Linked Comment